http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100480971-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-61 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00 |
filingDate | 2002-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2005-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2005-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100480971-B1 |
titleOfInvention | Antagonistic Compositions Against Dioxin-like Compounds Comprising Extract of Eugenia aromatica |
abstract | The present invention relates to an antagonistic composition for a dioxin-like substance having a clove extract as an active ingredient, and a pharmaceutical composition and a health food composition having the clove extract as an active ingredient, and more particularly, a clove extract as an active ingredient. It contains an antagonistic composition that inhibits the intracellular action of dioxin analogues by interfering with the XRE (xenobiotic response element) related signaling system of the analogues, and a pharmaceutically effective amount of clove extract. A pharmaceutical composition for treating or preventing a disease and a health food composition. The composition of the present invention not only effectively reduces the toxicity of the dioxin-like substance, but also contains a clove extract, which is a natural product that has been conventionally used as a drug, as an active ingredient, and because it exhibits an antagonistic action against the dioxin-like substance, Side effects are extremely low than chemical synthetic medicines. |
priorityDate | 2001-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 127.